Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Monopar Therapeutics (MNPR) stocks in Canada
Learn how to easily invest in Monopar Therapeutics stocks.
Monopar Therapeutics is a biotechnology business based in the US. Monopar Therapeutics stocks (MNPR.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.71 – a decrease of 5.07% over the previous week. Monopar Therapeutics employs 9 staff and has a market cap (total outstanding stock value) of $37.3 million.
How to buy shares in Monopar Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MNPR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Monopar Therapeutics?
- Has coronavirus impacted Monopar Therapeutics shares?
- Monopar Therapeutics shares summary
- Compare share dealing platforms
- Is Monopar Therapeutics stock a buy or sell?
- Monopar Therapeutics performance over time
- Monopar Therapeutics's financials
- How volatile are Monopar Therapeutics shares?
- Does Monopar Therapeutics pay a dividend?
- Other common questions
Monopar Therapeutics stock price (NASDAQ:MNPR)Use our graph to track the performance of MNPR stocks over time.
Monopar Therapeutics shares at a glance
|Latest market close||$2.81|
|52-week range||$2.76 - $11.60|
|50-day moving average||$4.04|
|200-day moving average||$5.01|
|Wall St. target price||$28.40|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.70|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Monopar Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Monopar Therapeutics price performance over time
|1 week (2022-01-14)||-5.07%|
|1 month (2021-12-23)||-15.87%|
|3 months (2021-10-22)||-38.65%|
|6 months (2021-07-23)||-49.37%|
|1 year (2021-01-22)||-59.84%|
|2 years (2020-01-24)||-82.97%|
|3 years (2019-01-20)||N/A|
|5 years (2017-01-20)||N/A|
Monopar Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-26.76%|
|Return on equity TTM||-44.11%|
|Market capitalisation||$37.3 million|
TTM: trailing 12 months
Monopar Therapeutics share dividends
We're not expecting Monopar Therapeutics to pay a dividend over the next 12 months.
Monopar Therapeutics share price volatility
Over the last 12 months, Monopar Therapeutics's shares have ranged in value from as little as $2.76 up to $11.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Monopar Therapeutics's is 0.9609. This would suggest that Monopar Therapeutics's shares are less volatile than average (for this exchange).
Monopar Therapeutics overview
Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the United States. It is involved in developing Validive, a clonidine mucobuccal tablet that is in Phase 2b/3 clinical trial for the treatment of radiation induced severe oral mucositis in oropharyngeal cancer patients; Camsirubicin, a topoisomerase II-alpha targeted analog of doxorubicin engineered to retain anticancer activity and for minimizing toxic effects on the heart, which is in Phase 2 clinical trial; and MNPR-101, a humanized monoclonal antibody for the treatment of advanced cancers and severe COVID-19 that is in preclinical stage. The company has a collaboration Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; and NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19. It also has a collaboration agreement with the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in multiple types of cancer. Monopar Therapeutics Inc. was founded in 2014 and is headquartered in Wilmette, Illinois.
Stocks similar to Monopar Therapeutics
Monopar Therapeutics in the news
What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020
Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more
Earnings playbook: A complete guide to this week's reports, including the first of tech
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.